JezK

Edit File: 1632640574.M449760P3209612.mocha3025.mochahost.com,S=116809,W=119242:2,S

Envelope-to: ahmad@jack.ngo,
 finance.advisor@jack.ngo,
 finance.manager@jack.ngo,
 haseeb.shirzada@jack.ngo,
 nooromari@jack.ngo,
 takal@jack.ngo
Delivery-date: Sun, 26 Sep 2021 03:16:14 -0400
From: <dr.safar@jack.ngo>
To: <takal@jack.ngo>
Cc: <ahmad@jack.ngo>,
	<nooromari@jack.ngo>,
	<haseeb.shirzada@jack.ngo>,
	<finance.manager@jack.ngo>,
	<finance.advisor@jack.ngo>
References: <007701d719a6$5153c930$f3fb5b90$@jack.ngo> <!&!AAAAAAAAAAAuAAAAAAAAAK+whLNHJnZLnYDb4fLeB80BAMO2jhD3dRHOtM0AqgC7tuYAAAAAAA4AABAAAADn+wNFvFnYSoPoAS9WN/N/AQAAAAA=@jack.ngo> <005e01d74040$648d85c0$2da89140$@jack.ngo> <!&!AAAAAAAAAAAuAAAAAAAAAK+whLNHJnZLnYDb4fLeB80BAMO2jhD3dRHOtM0AqgC7tuYAAAAAAA4AABAAAAC/LKTvAmgVSJSNjnP06dt3AQAAAAA=@jack.ngo> 
In-Reply-To: 
Subject: FW: Rejected and not received medicine
Date: Sun, 26 Sep 2021 11:46:06 +0430
Message-ID: <001c01d7b2a6$62daf130$2890d390$@jack.ngo>
MIME-Version: 1.0
Content-Type: multipart/related;
	boundary="----=_NextPart_000_001D_01D7B2CC.1AD92570"
Thread-Index: AQIwKTvpzDoM5QD4M3IF3aqBB1HSrgHFTt8gAVPZ+SsBiyelvwF3NjqEqtQZDcA=
Content-Language: en-us

This is a multipart message in MIME format.

------=_NextPart_000_001D_01D7B2CC.1AD92570
Content-Type: multipart/alternative;
	boundary="----=_NextPart_001_001E_01D7B2CC.1AD94C80"

------=_NextPart_001_001E_01D7B2CC.1AD94C80
Content-Type: text/plain;
	charset="utf-8"
Content-Transfer-Encoding: quoted-printable

Dear Takal Sahib

=20

As per pressure from Taliban at the time of implementing Trauma project =
in field, we had a request of medicine change from Main office, it was =
accepted and the cost was 23530 Afghanis.=20

The mission was to change 450 Falgyl Syrup to 450 Flagyl Serum and 2250 =
Salin 500ml to 2250 Saline 1000ml.

We received the total amount from supplier (450 Falgyl Serum and 2250 =
Salin 1000ml),=20

but we did not deliver the total amount we promised.

We delivered 295 Falgyl Syrup and 2230 Saline 500ml serums. We could not =
deliver 155 Flagyl Syrup and 30 Saline 500ml

=20

You can go through my previous email for the reasons.

=20

According to market prices, each Falgyl syrup is cost 33 Afghanis and =
each Serum Salin 500ml is cost 22 Afghanis.

155x33=3D 5115

30x22=3D 660

=20

In total 5775 Afghanis. This amount medicines were available in our =
FATPs, our Pharmacy assistant was not able to receive them, when we =
asked them after several days, he responded that the Taliban forcefully =
did not deliver the medicines.=20

=20

Beside from invoice, we have to pay 23530+5775=3D 29305 Afghanis to the =
supplier. The amount 5775 should be deducted from Pharmacy =
assistant=E2=80=99s salary (after clarification with him) and 23530 from =
any other financial line (the last quarter lines were not used in Kunduz =
province)

=20

Thank you & Best Regards

=20

Dr-Mohammad Hashim =E2=80=9CSafar=E2=80=9D MD/GP/Social Service Provider

Emergency projects Technical Manager

Just for Afghan Capacity and Knowledge       =D8=A8=D9=84=D9=86=D8=AF =
=D8=A8=D8=B1=D8=AF=D9=86 =D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =
=D9=88 =D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =
=D8=A7=D9=81=D8=BA=D8=A7=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9) =20

Address: Kunduz,Kocha Sinama,First Region

Beside Da Afghanistan Bank, House # 08

Ph: +93 787 047 554 - +93 744 990 143 - +93790807013 =E2=80=93 +93777 =
469 663

Official Email: <mailto:Dr.Safar@jack.ngo> Dr.Safar@jack.ngo

Personal Email: <mailto:Dr.Safar@yahoo.com> Dr.Safar@yahoo.com

Skype ID: <mailto:Dr.Safar001@outlook.com> Dr.Safar001@outlook.com =
 =20

Website:www.jack.ngo

=20

From: dr.safar@jack.ngo [mailto:dr.safar@jack.ngo]=20
Sent: Wednesday, August 4, 2021 11:01 AM
To: 'ahmad@jack.ngo' <ahmad@jack.ngo>
Cc: 'hadi@jack.ngo' <hadi@jack.ngo>; 'logistic.manager@jack.ngo' =
<logistic.manager@jack.ngo>; 'fatima.qasimi@jack.ngo' =
<fatima.qasimi@jack.ngo>; 'finance.manager@jack.ngo' =
<finance.manager@jack.ngo>; 'takal@jack.ngo' <takal@jack.ngo>; =
'nooromari@jack.ngo' <nooromari@jack.ngo>
Subject: RE: Rejected and not received medicine

=20

Dear Dr Ahmad

=20

As per below emails and justifications, 155 Flagyl syrups and 30 Serum =
saline were not delivered to the supplier according to our exchange =
plan.

=20

The exchange plan was to:=20

=C2=B7        450 Flagyl Syrup should have been replaced with 450 Flagyl =
solution

=C2=B7        2250 saline syrum of 500 Mile liter should have been =
replaced to 2250 Saline syrum 1000 Mile Liter

=20

295 flagyl syrup was delivered to the supplier, however, 155 was missed =
from Pharmacy assistant Mr Hakim Mangal as he said AOGs did not give =
them the exchanged Flagyl syrups.

=20

From 2250 Syrums, total 2220 Syrums were delivered to supplier. 30 =
syrums remained from the exchange, the reasons was when the first supply =
happened to Jan Qataghan, the syrums of 1000 Mile Liter was sent, =
however, the exchange of it was not brought back to stock. Later AOGs =
only gave them 420 syrums, 30 was used by FATP staff.

=20

Total: 155 Flagyl syrup and 30 Saline 500 Mile liter was left and the =
reason was that Mr Hakim Mangal sent the medicine to FATPs and did not =
bring back it=E2=80=99s exchange, he said AOGs did not permit.

The real was that Mr Mangal reported the issue after 3 days. When the =
issue was followed up, FATP staff said we have submitted and there were =
no documents for hand over/take over. Not having a clear document for =
takeover of medicine was the fault of Pharmacy assistant.

=20

Conclusion:  I would like to kindly request from top management team =
that declare their decision on the above mentioned issue. As it was =
raised by myself even months ago and there is no clear decision taken =
until now.

=20

Thanks in advance

=20

Thank you & Best Regards

=20

Dr-Mohammad Hashim =E2=80=9CSafar=E2=80=9D MD/GP/Social Service Provider

Emergency projects focal point / COVID-19 Vaccination technical focal =
point

Address: Kunduz,Kocha Sinama,First Region

Beside Da Afghanistan Bank, House # 08

Ph: +93 787 047 554 - +93 744 990 143 - +93790807013 =E2=80=93 +93777 =
469 663

Official Email: <mailto:Dr.Safar@jack.ngo> Dr.Safar@jack.ngo

Personal Email: <mailto:Dr.Safar@yahoo.com> Dr.Safar@yahoo.com

Website:www.jack.ngo

=20

From: pharmacy@jack.ngo <mailto:pharmacy@jack.ngo> =
[mailto:pharmacy@jack.ngo]=20
Sent: Monday, June 21, 2021 8:30 AM
To: fatima.qasimi@jack.ngo <mailto:fatima.qasimi@jack.ngo>=20
Cc: hadi@jack.ngo <mailto:hadi@jack.ngo> ; dr.safar@jack.ngo =
<mailto:dr.safar@jack.ngo> ; ahmad@jack.ngo <mailto:ahmad@jack.ngo>=20
Subject: FW: Rejected and not received medicine

=20

From: pharmacy@jack.ngo <mailto:pharmacy@jack.ngo> =
[mailto:pharmacy@jack.ngo]=20
Sent: Tuesday, May 4, 2021 1:28 PM
To: 'dr.safar@jack.ngo' <dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> >; =
'pharmacy.assistant@jack.ngo' <pharmacy.assistant@jack.ngo =
<mailto:pharmacy.assistant@jack.ngo> >; 'hamdard@jack.ngo' =
<hamdard@jack.ngo <mailto:hamdard@jack.ngo> >
Cc: 'ahmad@jack.ngo' <ahmad@jack.ngo <mailto:ahmad@jack.ngo> >; =
'hadi@jack.ngo' <hadi@jack.ngo <mailto:hadi@jack.ngo> >; =
'ghani@jack.ngo' <ghani@jack.ngo <mailto:ghani@jack.ngo> >; =
'takal@jack.ngo' <takal@jack.ngo <mailto:takal@jack.ngo> >; =
'mirzaee@jack.ngo' <mirzaee@jack.ngo <mailto:mirzaee@jack.ngo> >; =
'ahf-finance@jack.ngo' <ahf-finance@jack.ngo>; 'musawy@jack.ngo' =
<musawy@jack.ngo <mailto:musawy@jack.ngo> >; 'nooromari@jack.ngo' =
<nooromari@jack.ngo <mailto:nooromari@jack.ngo> >
Subject: RE: Rejected and not received medicine

=20

Dear Dr. Sahib Safar,

=20

Thanks from your email and justifications, the attached informal GRN =
shows that the medicines delivered to supplier without pharmacy =
committee and incomplete, but KDZ-AHF team promised to deliver complete =
rejected amount to supplier, the financial cost of this exchange was and =
will be:

1.      Complete exchange cost: 23,530 AFN=20

2.      Incomplete exchange cost: 41,590 AFN

As now the medicine delivered to supplier incompletely, I would like to =
know how we should pay 41,590 AFN to supplier, looking forward to hear =
from you soon.

=20

Dear En. Sahib Hadi,

=20

Kindly refer to below emails and let us know your comments.

=20

Regards

Jamal

=20

From: dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> =
[mailto:dr.safar@jack.ngo]=20
Sent: Monday, May 3, 2021 9:49 PM
To: pharmacy@jack.ngo <mailto:pharmacy@jack.ngo> ; =
pharmacy.assistant@jack.ngo <mailto:pharmacy.assistant@jack.ngo> ; =
hamdard@jack.ngo <mailto:hamdard@jack.ngo>=20
Cc: ahmad@jack.ngo <mailto:ahmad@jack.ngo> ; hadi@jack.ngo =
<mailto:hadi@jack.ngo> ; ghani@jack.ngo <mailto:ghani@jack.ngo> ; =
takal@jack.ngo <mailto:takal@jack.ngo> ; mirzaee@jack.ngo =
<mailto:mirzaee@jack.ngo> ; ahf-finance@jack.ngo =
<mailto:ahf-finance@jack.ngo> ; musawy@jack.ngo <mailto:musawy@jack.ngo> =
; nooromari@jack.ngo <mailto:nooromari@jack.ngo>=20
Subject: RE: Rejected and not received medicine

=20

Dear Dr Jamal

=20

As per investigations, I found out there are two problems.

1.      Only 295 flagyl syrups were submitted to Supplier, in this case, =
Haji Naim Jan clininc flagyl syrup were not received although Pharmacy =
assistant delivered Metrogyls, however he says the AOG responsible did =
not give me flagyl syrups

2.      When we delivered the sample medicine to Jan Qataghan of =
Khanabad district for AOG check up, the Salin 500 Ml syrums were sent as =
well, however after rejection, they were not collected back, due to AOG =
said rejected medicine should be replaced in FATP. When we wanted to =
deliver the 1000 Ml syrums of Salin, the pharmacy assistant did not =
collected salin 500 ml back. Then the ban started from march 12 =
=E2=80=93 2021 1st May 2021. Now when he called to the AOGs that we want =
our 450 Salin 500 mL syrums back, then AOG responsible replied that =
=E2=80=9Cnot collecting back the serums were NGOs fault and now we will =
not give it back we have sealed those serums and we will use it for our =
purpose=E2=80=9D.

=20

The conclusion: Two times the medicine were sent, however they were not =
collected back by Pharmacy assistant.=20

=20

The rest of the decision is up to Kabul Management team what they =
decide, the cleareance of each and every staff is up hold, the decision =
on this section is easy if the AOGs do not give us back serums and =
flagyl syrups.

=20

Currently I am communicating through community access mobilizer, will =
share the result of what is the final words of AOGs by tomorrow CoB.

=20

Dr-Mohammad Hashim =E2=80=9CSafar=E2=80=9D MD/GP/Social Service Provider

Project Manager-AHF Project

Address: Kunduz,Kocha Sinama,First Region

Beside Da Afghanistan Bank, House # 08

Ph: +93 787 047 554 - +93 744 990 143 - +93792711163

Email: <mailto:Dr.Safar@jack.ngo> Dr.Safar@jack.ngo

Email: <mailto:Parvez.Safar@gmail.com> Parvez.Safar@gmail.com=20

Website:www.jack.ngo

From: pharmacy@jack.ngo <mailto:pharmacy@jack.ngo> =
[mailto:pharmacy@jack.ngo]=20
Sent: Monday, May 3, 2021 1:18 PM
To: dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> ; =
pharmacy.assistant@jack.ngo <mailto:pharmacy.assistant@jack.ngo> ; =
hamdard@jack.ngo <mailto:hamdard@jack.ngo>=20
Cc: ahmad@jack.ngo <mailto:ahmad@jack.ngo> ; hadi@jack.ngo =
<mailto:hadi@jack.ngo> ; ghani@jack.ngo <mailto:ghani@jack.ngo> ; =
takal@jack.ngo <mailto:takal@jack.ngo> ; mirzaee@jack.ngo =
<mailto:mirzaee@jack.ngo> ; ahf-finance@jack.ngo =
<mailto:ahf-finance@jack.ngo> ; musawy@jack.ngo <mailto:musawy@jack.ngo> =
; nooromari@jack.ngo <mailto:nooromari@jack.ngo>=20
Subject: RE: Rejected and not received medicine

=20

Gentle Reminder!

=20

Dear AHF Team need your response regarding the subject issue, also let =
us know the way you delivered medicine to supplier along with delivered =
amount, looking forward to hear from you soon.

=20

Regards

Jamal

=20

From: pharmacy@jack.ngo <mailto:pharmacy@jack.ngo> =
[mailto:pharmacy@jack.ngo]=20
Sent: Saturday, May 1, 2021 1:53 PM
To: 'dr.safar@jack.ngo' <dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> >; =
'pharmacy.assistant@jack.ngo' <pharmacy.assistant@jack.ngo =
<mailto:pharmacy.assistant@jack.ngo> >; 'hamdard@jack.ngo' =
<hamdard@jack.ngo <mailto:hamdard@jack.ngo> >
Cc: 'ahmad@jack.ngo' <ahmad@jack.ngo <mailto:ahmad@jack.ngo> >; =
'hadi@jack.ngo' <hadi@jack.ngo <mailto:hadi@jack.ngo> >; =
'ghani@jack.ngo' <ghani@jack.ngo <mailto:ghani@jack.ngo> >; =
'takal@jack.ngo' <takal@jack.ngo <mailto:takal@jack.ngo> >; =
'mirzaee@jack.ngo' <mirzaee@jack.ngo <mailto:mirzaee@jack.ngo> >; =
'ahf-finance@jack.ngo' <ahf-finance@jack.ngo =
<mailto:ahf-finance@jack.ngo> >; 'musawy@jack.ngo' <musawy@jack.ngo =
<mailto:musawy@jack.ngo> >
Subject: RE: Rejected and not received medicine

=20

Dear Dr. Safar and Amrullah Khan,

=20

I hope you have been well, based on your request and top management =
approval we have exchanged the rejected medicine to requested medicine =
which your all fully aware of that, now we have pay 23,530 AFN to =
supplier due to exchange rate, to let you know finance team will pay the =
main procurement cost to supplier only exchange cost rate will be paid =
by you as it was agreed, attached is the supplier bank details, if there =
be any question please contact to finance team.

=20

Regards

Jamal

=20

From: pharmacy@jack.ngo [mailto:pharmacy@jack.ngo]=20
Sent: Tuesday, March 30, 2021 10:26 AM
To: 'dr.safar@jack.ngo' <dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> >; =
'pharmacy.assistant@jack.ngo' <pharmacy.assistant@jack.ngo =
<mailto:pharmacy.assistant@jack.ngo> >; 'hamdard@jack.ngo' =
<hamdard@jack.ngo <mailto:hamdard@jack.ngo> >
Cc: 'ahmad@jack.ngo' <ahmad@jack.ngo <mailto:ahmad@jack.ngo> >; =
'hadi@jack.ngo' <hadi@jack.ngo <mailto:hadi@jack.ngo> >; =
'ghani@jack.ngo' <ghani@jack.ngo <mailto:ghani@jack.ngo> >; =
'takal@jack.ngo' <takal@jack.ngo <mailto:takal@jack.ngo> >; =
'mirzaee@jack.ngo' <mirzaee@jack.ngo <mailto:mirzaee@jack.ngo> >; =
'ahf-finance@jack.ngo' <ahf-finance@jack.ngo =
<mailto:ahf-finance@jack.ngo> >; 'musawy@jack.ngo' <musawy@jack.ngo =
<mailto:musawy@jack.ngo> >
Subject: RE: Rejected and not received medicine

=20

Dear Dr. Safar,

=20

I am glad that you received the requested medicine for 4th Qtr of AHF =
project, which I didn=E2=80=99t get your confirmation nor GRN, please =
let me know about following comments:

1.      Vicryl 4/1 is not available at the market, which size will be =
the alternative (Vicryl size 4 or Vicryl size 1).

2.      Per your request and senior management approval we discussed and =
agreed with supplier to exchange the two rejected items (Serum-Saline =
500ml & Syrup-Metro 200mg/30ml) to requested items (Serum-Saline 1000ml =
& Serum-Metro 500mg/30ml) beyond the main contract, now supplier is =
confused that when I will receive the exchanged items because he already =
send his representative three times to PO-M.Stock, in order to receive =
the exchange medicine but due to none reason the process get postponed, =
I would like to know if there is any problem and the exact time when =
your able to deliver the exchanged items to supplier.

Please let me know if there is anything that I can help you to =
accelerate the process and close the procurement process.

=20

Best Regards,

=20

JAMAL   Pharm.D

Procurement / Pharmacy Manger

Address: 1st Street of Karta-e-Chahar, Kabul Afghanistan=20

Behind AWCC Main Office, House # 09

What=E2=80=99s app: +93 744 402 619

Email: pharm.dmrjamal@gmail.com <mailto:pharm.dmrjamal@gmail.com> =20

Website:www.jack.ngo=20

=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D

This e-mail and any files transmitted with it may contain privileged or =
confidential information. It is solely for use by the individual for =
whom it is intended, even if addressed incorrectly. If you received this =
e-mail in error, please notify the sender; do not disclose copy, =
distribute, or take any action in reliance on the contents of this =
information; and delete it from your system. Any other use of this =
e-mail is prohibited. The views expressed herein are those of the author =
and do not necessarily reflect the views or policies of jack =
(Afghanistan). Electronic transmissions may be recorded and =
monitored.For Verification Please Read the Barcode Reader. =20

=09
	=09
=20

=20

P Every 3000 sheets of paper costs us a tree. Please don't print this =
e-mail unless you really need to

=20

From: pharmacy@jack.ngo <mailto:pharmacy@jack.ngo> =
[mailto:pharmacy@jack.ngo]=20
Sent: Tuesday, March 16, 2021 10:13 AM
To: 'dr.safar@jack.ngo' <dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> >; =
'pharmacy.assistant@jack.ngo' <pharmacy.assistant@jack.ngo =
<mailto:pharmacy.assistant@jack.ngo> >; 'hamdard@jack.ngo' =
<hamdard@jack.ngo <mailto:hamdard@jack.ngo> >
Cc: 'ahmad@jack.ngo' <ahmad@jack.ngo <mailto:ahmad@jack.ngo> >; =
'hadi@jack.ngo' <hadi@jack.ngo <mailto:hadi@jack.ngo> >; =
'ghani@jack.ngo' <ghani@jack.ngo <mailto:ghani@jack.ngo> >; =
'takal@jack.ngo' <takal@jack.ngo <mailto:takal@jack.ngo> >; =
'mirzaee@jack.ngo' <mirzaee@jack.ngo <mailto:mirzaee@jack.ngo> >; =
'ahf-finance@jack.ngo' <ahf-finance@jack.ngo =
<mailto:ahf-finance@jack.ngo> >; 'musawy@jack.ngo' <musawy@jack.ngo =
<mailto:musawy@jack.ngo> >
Subject: RE: Rejected and not received medicine

=20

Dear Dr. Sahib Safar,

=20

Thanks from your email, please review below comments:

1.      I received the draft of GRN and I found difference at 11 items, =
as I shared the list with supplier he send his representative to PO to =
solve the supply issue immediately, again I will follow this issue with =
supplier and will communicate you via phone.

2.      As we have agreed with supplier to exchange the two items which =
are quarantine right now at P-Stock and you received the replacement, =
please make them ready and pack in exact Qty and good package, please do =
the exchange process in presence of pharmacy committee.

3.      As I already talked with pharmacy team, so please inform them to =
prepare the GRN with all required info such as (expiry date, batch =
number, company & country, Qty, etc..).

4.      As you all aware that AHF-Projects will be audit by 3rd party =
team, so please inform the AHF pharmacy in charge to fully get ready for =
assessment.

=20

Regards

Jamal

=20

From: dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> =
[mailto:dr.safar@jack.ngo]=20
Sent: Monday, March 15, 2021 6:50 PM
To: logitic.manager@jack.ngo <mailto:logitic.manager@jack.ngo>=20
Cc: ahmad@jack.ngo <mailto:ahmad@jack.ngo> ; hadi@jack.ngo =
<mailto:hadi@jack.ngo> ; ghani@jack.ngo <mailto:ghani@jack.ngo> ; =
takal@jack.ngo <mailto:takal@jack.ngo> ; mirzaee@jack.ngo =
<mailto:mirzaee@jack.ngo> ; ahf-finance@jack.ngo =
<mailto:ahf-finance@jack.ngo> ; pharmacy@jack.ngo =
<mailto:pharmacy@jack.ngo>=20
Subject: Rejected and not received medicine

=20

Dear Dr Sahib Jamal

Greetings from Kunduz office

=20

First of all thank you very much for a very quick procurement of AHF =
trauma medicine, the quality and the quantitiy is good and appreciated.

=20

However, there are difference in 11 items, as we explained and the =
report was shared with the pharmacy/warehouse responsible. I hope it has =
reached to you and I would like to kindly request on the process speed =
up.=20

=20

I would be glad to hear from your dear dr Sahib.

=20

Thank you & Best Regards

=20

Dr-Mohammad Hashim =E2=80=9CSafar=E2=80=9D MD/GP/Social Service Provider

Project Manager-AHF Project / NER PSEA Focal Point / Mental Health Focal =
Point

Address: Kunduz,Kocha Sinama,First Region

Beside Da Afghanistan Bank, House # 08

Ph: +93 787 047 554 - +93 744 990 143 - +93792 716 026 =E2=80=93 +93777 =
469 663 =E2=80=93 +93706 179 758

Official Email: <mailto:Dr.Safar@jack.ngo> Dr.Safar@jack.ngo

Personal Email: <mailto:Dr.Safar001@outlook.com> =
Dr.Safar001@outlook.com =E2=80=93 <mailto:Dr.Safar@yahoo.com> =
Dr.Safar@yahoo.com

Website:www.jack.ngo

=20

------=_NextPart_001_001E_01D7B2CC.1AD94C80
Content-Type: text/html;
	charset="utf-8"
Content-Transfer-Encoding: quoted-printable

<html xmlns:v=3D"urn:schemas-microsoft-com:vml" =
xmlns:o=3D"urn:schemas-microsoft-com:office:office" =
xmlns:w=3D"urn:schemas-microsoft-com:office:word" =
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml" =
xmlns=3D"http://www.w3.org/TR/REC-html40"><head><meta =
http-equiv=3DContent-Type content=3D"text/html; charset=3Dutf-8"><meta =
name=3DGenerator content=3D"Microsoft Word 15 (filtered medium)"><style></style></head><body lang=3DEN-US =
link=3D"#0563C1" vlink=3D"#954F72"><div class=3DWordSection1><a name=3D"_MailEndCompose">Dear Takal Sahib<o:p></o:p></a><o:p>&nbsp;</o:p>As per pressure from =
Taliban at the time of implementing Trauma project in field, we had a =
request of medicine change from Main office, it was accepted and the =
cost was 23530 Afghanis. <o:p></o:p>The mission was to =
change 450 Falgyl Syrup to 450 Flagyl Serum and 2250 Salin 500ml to 2250 =
Saline 1000ml.<o:p></o:p>We received the total amount from supplier (450 =
Falgyl Serum and 2250 Salin 1000ml), <o:p></o:p>but we did not deliver =
the total amount we promised.<o:p></o:p>We delivered 295 Falgyl =
Syrup and 2230 Saline 500ml serums. We could not deliver 155 Flagyl =
Syrup and 30 Saline 500ml<o:p></o:p><o:p>&nbsp;</o:p>You can go through my =
previous email for the reasons.<o:p></o:p><o:p>&nbsp;</o:p>According to market =
prices, each Falgyl syrup is cost 33 Afghanis and each Serum Salin 500ml =
is cost 22 Afghanis.<o:p></o:p>155x33=3D 5115<o:p></o:p>30x22=3D =
660<o:p></o:p><o:p>&nbsp;</o:p>In total 5775 Afghanis. =
This amount medicines were available in our FATPs, our Pharmacy =
assistant was not able to receive them, when we asked them after several =
days, he responded that the Taliban forcefully did not deliver the =
medicines. <o:p></o:p><o:p>&nbsp;</o:p>Beside from invoice, we =
have to pay 23530+5775=3D 29305 Afghanis to the supplier. The amount =
5775 should be deducted from Pharmacy assistant=E2=80=99s salary (after =
clarification with him) and 23530 from any other financial line (the =
last quarter lines were not used in Kunduz =
province)<o:p></o:p><o:p>&nbsp;</o:p><div>Thank you &amp; Best =
Regards<o:p></o:p><o:p>&nbsp;</o:p><=
img width=3D239 height=3D85 id=3D"Picture_x0020_2" =
src=3D"cid:image001.jpg@01D7B2CC.17090AA0"><o:p></o:p><=
o:p>&nbsp;</o:p><=
img width=3D236 height=3D99 id=3D"Picture_x0020_3" =
src=3D"cid:image002.jpg@01D7B2CC.17090AA0"><o:p></o:p>&n=
bsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<o:p></o:p>Dr-Mohammad Hashim =E2=80=9CSafar=E2=80=9D =
MD/GP/Social Service =
Provider<o:p></o:p>Emergency projects Technical =
Manager<o:p></o:p>Just for Afghan Capacity and =
Knowledge&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
&nbsp;=D8=A8=D9=84=D9=86=D8=AF =D8=A8=D8=B1=D8=AF=D9=86 =
=D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =D9=88 =
=D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =
=D8=A7=D9=81=D8=BA=D8=A7=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9)&nbsp; =
<o:p></o:p>Address: Kunduz,Kocha Sinama,First =
Region<o:p></o:p>Beside Da Afghanistan Bank, House # =
08<o:p></o:p>Ph: +93 787 047 554 - +93 744 990 143 - =
+93790807013 =E2=80=93 +93777 469 663<o:p></o:p>Official Email: <a =
href=3D"mailto:Dr.Safar@jack.ngo">Dr.Safar@jack.ngo</a><o:p></o:p>Personal Email: &nbsp;<a =
href=3D"mailto:Dr.Safar@yahoo.com">Dr.Safar@yahoo.com</a><o:p></o:p>Skype ID: <a =
href=3D"mailto:Dr.Safar001@outlook.com">Dr.Safar001@outlook.com</a>=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=A0=C2=
=A0=C2=A0=C2=A0 <o:p></o:p>Website:www.jack.ngo<o:p></o:p><=
/div><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: dr.safar@jack.ngo =
[mailto:dr.safar@jack.ngo] Sent: Wednesday, August 4, 2021 =
11:01 AM To: 'ahmad@jack.ngo' =
&lt;ahmad@jack.ngo&gt; Cc: 'hadi@jack.ngo' =
&lt;hadi@jack.ngo&gt;; 'logistic.manager@jack.ngo' =
&lt;logistic.manager@jack.ngo&gt;; 'fatima.qasimi@jack.ngo' =
&lt;fatima.qasimi@jack.ngo&gt;; 'finance.manager@jack.ngo' =
&lt;finance.manager@jack.ngo&gt;; 'takal@jack.ngo' =
&lt;takal@jack.ngo&gt;; 'nooromari@jack.ngo' =
&lt;nooromari@jack.ngo&gt; Subject: RE: Rejected and not =
received medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Dr Ahmad<o:p></o:p><o:p>&nbsp;</o:p>As per below emails and =
justifications, 155 Flagyl syrups and 30 Serum saline were not delivered =
to the supplier according to our exchange plan.<o:p></o:p><o:p>&nbsp;</o:p>The exchange plan was =
to: <o:p></o:p><![if =
!supportLists]>=C2=B7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>450 Flagyl Syrup should have been replaced with =
450 Flagyl solution<o:p></o:p><![if =
!supportLists]>=C2=B7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>2250 saline syrum of 500 Mile liter should have =
been replaced to 2250 Saline syrum 1000 Mile =
Liter<o:p></o:p><o:p>&nbsp;</o:p>295 flagyl syrup was =
delivered to the supplier, however, 155 was missed from Pharmacy =
assistant Mr Hakim Mangal as he said AOGs did not give them the =
exchanged Flagyl syrups.<o:p></o:p><o:p>&nbsp;</o:p>From 2250 Syrums, total =
2220 Syrums were delivered to supplier. 30 syrums remained from the =
exchange, the reasons was when the first supply happened to Jan =
Qataghan, the syrums of 1000 Mile Liter was sent, however, the exchange =
of it was not brought back to stock. Later AOGs only gave them 420 =
syrums, 30 was used by FATP staff.<o:p></o:p><o:p>&nbsp;</o:p>Total: 155 Flagyl syrup and 30 Saline 500 Mile liter =
was left and the reason was that Mr Hakim Mangal sent the medicine to =
FATPs and did not bring back it=E2=80=99s exchange, he said AOGs did not =
permit.<o:p></o:p>The real was that Mr Mangal reported the issue =
after 3 days. When the issue was followed up, FATP staff said we have =
submitted and there were no documents for hand over/take over. Not =
having a clear document for takeover of medicine was the fault of =
Pharmacy assistant.<o:p></o:p><o:p>&nbsp;</o:p>Conclusion: =
&nbsp;I would like to kindly =
request from top management team that declare their decision on the =
above mentioned issue. As it was raised by myself even months ago and =
there is no clear decision taken until now.<o:p></o:p><o:p>&nbsp;</o:p>Thanks in =
advance<o:p></o:p><o:p>&nbsp;</o:p><div>Thank you &amp; Best =
Regards<o:p></o:p><img border=3D0 width=3D61 =
height=3D48 id=3D"_x0000_i1025" =
src=3D"cid:image003.jpg@01D7891A.FD9F0090" =
alt=3D"cid:image003.jpg@01D4B669.F250F440"><=
o:p></o:p>&n=
bsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<o:p></o:p>Dr-Mohammad Hashim =E2=80=9CSafar=E2=80=9D =
MD/GP/Social Service =
Provider<o:p></o:p>Emergency projects focal point / COVID-19 =
Vaccination technical focal point<o:p></o:p>Just for Afghan Capacity and =
Knowledge&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
&nbsp;=D8=A8=D9=84=D9=86=D8=AF =D8=A8=D8=B1=D8=AF=D9=86 =
=D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =D9=88 =
=D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =
=D8=A7=D9=81=D8=BA=D8=A7=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9)&nbsp; =
<o:p></o:p>Address: Kunduz,Kocha Sinama,First =
Region<o:p></o:p>Beside Da Afghanistan Bank, House # =
08<o:p></o:p>Ph: +93 787 047 554 - +93 744 990 143 - =
+93790807013 =E2=80=93 +93777 469 663<o:p></o:p>Official Email: <a =
href=3D"mailto:Dr.Safar@jack.ngo">Dr.Safar@jack.ngo</a><o:p></o:p>Personal Email: &nbsp;<a =
href=3D"mailto:Dr.Safar@yahoo.com">Dr.Safar@yahoo.com</a><o:p></o:p>Website:www.jack.ngo<o:p></o:p><=
/div><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a> [<a =
href=3D"mailto:pharmacy@jack.ngo">mailto:pharmacy@jack.ngo</a>] =
 Sent: Monday, June 21, 2021 8:30 AM To: <a =
href=3D"mailto:fatima.qasimi@jack.ngo">fatima.qasimi@jack.ngo</a> C=
c: <a href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>; <a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a>; <a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a> Subject: FW: =
Rejected and not received medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a> [<a =
href=3D"mailto:pharmacy@jack.ngo">mailto:pharmacy@jack.ngo</a>] =
 Sent: Tuesday, May 4, 2021 1:28 PM To: =
'dr.safar@jack.ngo' &lt;<a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a>&gt;; =
'pharmacy.assistant@jack.ngo' &lt;<a =
href=3D"mailto:pharmacy.assistant@jack.ngo">pharmacy.assistant@jack.ngo</=
a>&gt;; 'hamdard@jack.ngo' &lt;<a =
href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a>&gt; Cc: =
'ahmad@jack.ngo' &lt;<a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>&gt;; 'hadi@jack.ngo' =
&lt;<a href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>&gt;; =
'ghani@jack.ngo' &lt;<a =
href=3D"mailto:ghani@jack.ngo">ghani@jack.ngo</a>&gt;; 'takal@jack.ngo' =
&lt;<a href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>&gt;; =
'mirzaee@jack.ngo' &lt;<a =
href=3D"mailto:mirzaee@jack.ngo">mirzaee@jack.ngo</a>&gt;; =
'ahf-finance@jack.ngo' &lt;<a =
href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>&gt;; =
'musawy@jack.ngo' &lt;<a =
href=3D"mailto:musawy@jack.ngo">musawy@jack.ngo</a>&gt;; =
'nooromari@jack.ngo' &lt;<a =
href=3D"mailto:nooromari@jack.ngo">nooromari@jack.ngo</a>&gt; Subje=
ct: RE: Rejected and not received =
medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Dr. Sahib Safar,<o:p></o:p><o:p>&nbsp;</o:p>Thanks from your email =
and justifications, the attached informal GRN shows that the medicines =
delivered to supplier without pharmacy committee and incomplete, but =
KDZ-AHF team promised to deliver complete rejected amount to supplier, =
the financial cost of this exchange was and will =
be:<o:p></o:p><![if =
!supportLists]>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>Complete exchange cost: 23,530 AFN =
<o:p></o:p><![if =
!supportLists]>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>Incomplete exchange cost: 41,590 =
AFN<o:p></o:p>As now the medicine delivered to supplier =
incompletely, I would like to know how we should pay 41,590 AFN to =
supplier, looking forward to hear from you soon.<o:p></o:p><o:p>&nbsp;</o:p>Dear En. Sahib =
Hadi,<o:p></o:p><o:p>&nbsp;</o:p>Kindly refer to below =
emails and let us know your comments.<o:p></o:p><o:p>&nbsp;</o:p>Regards<o:p></o:p>Jamal<o:p></o:p><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a> [<a =
href=3D"mailto:dr.safar@jack.ngo">mailto:dr.safar@jack.ngo</a>] =
 Sent: Monday, May 3, 2021 9:49 PM To: <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a>; <a =
href=3D"mailto:pharmacy.assistant@jack.ngo">pharmacy.assistant@jack.ngo</=
a>; <a =
href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a> Cc: <a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>; <a =
href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>; <a =
href=3D"mailto:ghani@jack.ngo">ghani@jack.ngo</a>; <a =
href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>; <a =
href=3D"mailto:mirzaee@jack.ngo">mirzaee@jack.ngo</a>; <a =
href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>; <a =
href=3D"mailto:musawy@jack.ngo">musawy@jack.ngo</a>; <a =
href=3D"mailto:nooromari@jack.ngo">nooromari@jack.ngo</a> Subject:<=
/b> RE: Rejected and not received medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Dr Jamal<o:p></o:p><o:p>&nbsp;</o:p>As per investigations, I =
found out there are two problems.<o:p></o:p><![if !supportLists]>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>Only 295 flagyl syrups were submitted to =
Supplier, in this case, Haji Naim Jan clininc flagyl syrup were not =
received although Pharmacy assistant delivered Metrogyls, however he =
says the AOG responsible did not give me flagyl =
syrups<o:p></o:p><![if =
!supportLists]>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>When we delivered the sample medicine to Jan =
Qataghan of Khanabad district for AOG check up, the Salin 500 Ml syrums =
were sent as well, however after rejection, they were not collected =
back, due to AOG said rejected medicine should be replaced in FATP. When =
we wanted to deliver the 1000 Ml syrums of Salin, the pharmacy assistant =
did not collected salin 500 ml back. Then the ban started from march 12 =
=E2=80=93 2021 1st May 2021. Now when he called to the AOGs =
that we want our 450 Salin 500 mL syrums back, then AOG responsible =
replied that =E2=80=9Cnot collecting back the serums were NGOs fault and =
now we will not give it back we have sealed those serums and we will use =
it for our purpose=E2=80=9D.<o:p></o:p><o:p>&nbsp;</o:p>The conclusion: Two =
times the medicine were sent, however they were not collected back by =
Pharmacy assistant. <o:p></o:p><o:p>&nbsp;</o:p>The rest of the decision =
is up to Kabul Management team what they decide, the cleareance of each =
and every staff is up hold, the decision on this section is easy if the =
AOGs do not give us back serums and flagyl =
syrups.<o:p></o:p><o:p>&nbsp;</o:p>Currently I am =
communicating through community access mobilizer, will share the result =
of what is the final words of AOGs by tomorrow =
CoB.<o:p></o:p><o:p>&nbsp;</o:p>Dr-Mohammad Hashim =E2=80=9CSafar=E2=80=9D =
MD/GP/Social Service =
Provider<o:p></o:p>Project Manager-AHF =
Project<o:p></o:p>Just for Afghan Capacity and =
Knowledge&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
&nbsp;=D8=A8=D9=84=D9=86=D8=AF =D8=A8=D8=B1=D8=AF=D9=86 =
=D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =D9=88 =
=D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =
=D8=A7=D9=81=D8=BA=D8=A7=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9)&nbsp; =
<o:p></o:p>Address: Kunduz,Kocha Sinama,First =
Region<o:p></o:p>Beside Da Afghanistan Bank, House # =
08<o:p></o:p>Ph: +93 787 047 554 - +93 744 990 143 - =
+93792711163<o:p></o:p>Email: <a =
href=3D"mailto:Dr.Safar@jack.ngo">Dr.Safar@jack.ngo</a><o:p></o:p>Email: <a =
href=3D"mailto:Parvez.Safar@gmail.com">Parvez.Safar@gmail.com</a> <o:p></o:p>Website:www.jack.ngo<o:p></o:p><=
div><div style=3D'border:none;border-top:solid #E1E1E1 =
1.0pt;padding:3.0pt 0in 0in 0in'>From: <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a> [<a =
href=3D"mailto:pharmacy@jack.ngo">mailto:pharmacy@jack.ngo</a>] =
 Sent: Monday, May 3, 2021 1:18 PM To: <a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a>; <a =
href=3D"mailto:pharmacy.assistant@jack.ngo">pharmacy.assistant@jack.ngo</=
a>; <a =
href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a> Cc: <a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>; <a =
href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>; <a =
href=3D"mailto:ghani@jack.ngo">ghani@jack.ngo</a>; <a =
href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>; <a =
href=3D"mailto:mirzaee@jack.ngo">mirzaee@jack.ngo</a>; <a =
href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>; <a =
href=3D"mailto:musawy@jack.ngo">musawy@jack.ngo</a>; <a =
href=3D"mailto:nooromari@jack.ngo">nooromari@jack.ngo</a> Subject:<=
/b> RE: Rejected and not received medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p>Gentle Reminder!<o:p></o:p><o:p>&nbsp;</o:p>Dear AHF Team need your =
response regarding the subject issue, also let us know the way you =
delivered medicine to supplier along with delivered amount, looking =
forward to hear from you soon.<o:p></o:p><o:p>&nbsp;</o:p>Regards<o:p></o:p>Jamal<o:p></o:p><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a> [<a =
href=3D"mailto:pharmacy@jack.ngo">mailto:pharmacy@jack.ngo</a>] =
 Sent: Saturday, May 1, 2021 1:53 PM To: =
'dr.safar@jack.ngo' &lt;<a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a>&gt;; =
'pharmacy.assistant@jack.ngo' &lt;<a =
href=3D"mailto:pharmacy.assistant@jack.ngo">pharmacy.assistant@jack.ngo</=
a>&gt;; 'hamdard@jack.ngo' &lt;<a =
href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a>&gt; Cc: =
'ahmad@jack.ngo' &lt;<a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>&gt;; 'hadi@jack.ngo' =
&lt;<a href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>&gt;; =
'ghani@jack.ngo' &lt;<a =
href=3D"mailto:ghani@jack.ngo">ghani@jack.ngo</a>&gt;; 'takal@jack.ngo' =
&lt;<a href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>&gt;; =
'mirzaee@jack.ngo' &lt;<a =
href=3D"mailto:mirzaee@jack.ngo">mirzaee@jack.ngo</a>&gt;; =
'ahf-finance@jack.ngo' &lt;<a =
href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>&gt;; =
'musawy@jack.ngo' &lt;<a =
href=3D"mailto:musawy@jack.ngo">musawy@jack.ngo</a>&gt; Subject:</b=
> RE: Rejected and not received medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Dr. Safar and Amrullah =
Khan,<o:p></o:p><o:p>&nbsp;</o:p>I hope you have been =
well, based on your request and top management approval we have =
exchanged the rejected medicine to requested medicine which your all =
fully aware of that, now we have pay 23,530 AFN to supplier due to =
exchange rate, to let you know finance team will pay the main =
procurement cost to supplier only exchange cost rate will be paid by you =
as it was agreed, attached is the supplier bank details, if there be any =
question please contact to finance team.<o:p></o:p><o:p>&nbsp;</o:p>Regards<o:p></o:p>Jamal<o:p></o:p><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a> [<a =
href=3D"mailto:pharmacy@jack.ngo">mailto:pharmacy@jack.ngo</a>] =
 Sent: Tuesday, March 30, 2021 10:26 AM To: =
'dr.safar@jack.ngo' &lt;<a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a>&gt;; =
'pharmacy.assistant@jack.ngo' &lt;<a =
href=3D"mailto:pharmacy.assistant@jack.ngo">pharmacy.assistant@jack.ngo</=
a>&gt;; 'hamdard@jack.ngo' &lt;<a =
href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a>&gt; Cc: =
'ahmad@jack.ngo' &lt;<a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>&gt;; 'hadi@jack.ngo' =
&lt;<a href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>&gt;; =
'ghani@jack.ngo' &lt;<a =
href=3D"mailto:ghani@jack.ngo">ghani@jack.ngo</a>&gt;; 'takal@jack.ngo' =
&lt;<a href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>&gt;; =
'mirzaee@jack.ngo' &lt;<a =
href=3D"mailto:mirzaee@jack.ngo">mirzaee@jack.ngo</a>&gt;; =
'ahf-finance@jack.ngo' &lt;<a =
href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>&gt;; =
'musawy@jack.ngo' &lt;<a =
href=3D"mailto:musawy@jack.ngo">musawy@jack.ngo</a>&gt; Subject:</b=
> RE: Rejected and not received medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Dr. Safar,<o:p></o:p><o:p>&nbsp;</o:p>I am glad that you =
received the requested medicine for 4th Qtr of AHF project, =
which I didn=E2=80=99t get your confirmation nor GRN, please let me know =
about following comments:<o:p></o:p><![if !supportLists]>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>Vicryl 4/1 is not available at the market, which =
size will be the alternative (Vicryl size 4 or Vicryl size =
1).<o:p></o:p><![if =
!supportLists]>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>Per your request and senior management approval =
we discussed and agreed with supplier to exchange the two rejected items =
(Serum-Saline 500ml &amp; Syrup-Metro 200mg/30ml) to requested items =
(Serum-Saline 1000ml &amp; Serum-Metro 500mg/30ml) beyond the main =
contract, now supplier is confused that when I will receive the =
exchanged items because he already send his representative three times =
to PO-M.Stock, in order to receive the exchange medicine but due to none =
reason the process get postponed, I would like to know if there is any =
problem and the exact time when your able to deliver the exchanged items =
to supplier.<o:p></o:p>Please let me know if there is anything that I =
can help you to accelerate the process and close the procurement =
process.<o:p></o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p>Best =
Regards,<o:p></o:p><o:p>&nbsp;</o:p><img border=3D0 =
width=3D49 height=3D38 id=3D"Picture_x0020_1" =
src=3D"cid:image006.jpg@01D7891A.FD9F0090" =
alt=3D"cid:image003.jpg@01D4B669.F250F440"><=
o:p></o:p>&n=
bsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<o:p></o:p>JAMAL&nbsp;&nbsp; Pharm.D<o:p></o:p>Procurement / Pharmacy =
Manger<o:p></o:p>Just for Afghan Capacity and =
Knowledge&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
&nbsp;=D8=A8=D9=84=D9=86=D8=AF =D8=A8=D8=B1=D8=AF=D9=86 =
=D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =D9=88 =
=D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =
=D8=A7=D9=81=D8=BA=D8=A7=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9)&nbsp; =
<o:p></o:p>Address: 1st Street of Karta-e-Chahar, =
Kabul Afghanistan <o:p></o:p>Behind AWCC Main Office, House # =
09<o:p></o:p>What=E2=80=99s app: +93 744 402 =
619<o:p></o:p>Email: <a =
href=3D"mailto:pharm.dmrjamal@gmail.com">pharm.dmrjamal@gmail.com</a></sp=
an>&nbsp; <o:p></o:p>Website:www.jack.ngo <o:p></o:p>=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
<o:p></o:p>This e-mail and any files =
transmitted with it may contain privileged or confidential information. =
It is solely for use by the individual for whom it is intended, even if =
addressed incorrectly. If you received this e-mail in error, please =
notify the sender; do not disclose copy, distribute, or take any action =
in reliance on the contents of this information; and delete it from your =
system. Any other use of this e-mail is prohibited. The views expressed =
herein are those of the author and do not necessarily reflect the views =
or policies of jack (Afghanistan). Electronic transmissions may be =
recorded and monitored.For Verification Please Read =
the Barcode Reader.&nbsp; <o:p></o:p><![if !vml]><table cellpadding=3D0 cellspacing=3D0 =
align=3Dleft><tr><td width=3D2 =
height=3D1198></td></tr><tr><td></td><td><img width=3D115 height=3D115 =
src=3D"cid:image005.jpg@01D7B2CC.17090AA0" alt=3D"jack smart code" =
v:shapes=3D"Picture_x0020_1"></td></tr></table><![endif]><o:p>&nbsp;</o:p></=
p><o:p>&nbsp;</o:p><o:p>&nbsp;</=
o:p><o:p>&nbsp;</=
o:p> P<s=
pan =
style=3D'font-size:7.5pt;font-family:"Arial",sans-serif;color:green'> =
Ever=
y 3000 sheets of paper costs us a tree. Please don't print this e-mail =
unless you really need to<o:p></o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a> [<a =
href=3D"mailto:pharmacy@jack.ngo">mailto:pharmacy@jack.ngo</a>] =
 Sent: Tuesday, March 16, 2021 10:13 AM To: =
'dr.safar@jack.ngo' &lt;<a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a>&gt;; =
'pharmacy.assistant@jack.ngo' &lt;<a =
href=3D"mailto:pharmacy.assistant@jack.ngo">pharmacy.assistant@jack.ngo</=
a>&gt;; 'hamdard@jack.ngo' &lt;<a =
href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a>&gt; Cc: =
'ahmad@jack.ngo' &lt;<a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>&gt;; 'hadi@jack.ngo' =
&lt;<a href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>&gt;; =
'ghani@jack.ngo' &lt;<a =
href=3D"mailto:ghani@jack.ngo">ghani@jack.ngo</a>&gt;; 'takal@jack.ngo' =
&lt;<a href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>&gt;; =
'mirzaee@jack.ngo' &lt;<a =
href=3D"mailto:mirzaee@jack.ngo">mirzaee@jack.ngo</a>&gt;; =
'ahf-finance@jack.ngo' &lt;<a =
href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>&gt;; =
'musawy@jack.ngo' &lt;<a =
href=3D"mailto:musawy@jack.ngo">musawy@jack.ngo</a>&gt; Subject:</b=
> RE: Rejected and not received medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Dr. Sahib Safar,<o:p></o:p><o:p>&nbsp;</o:p>Thanks from your email, =
please review below comments:<o:p></o:p><![if !supportLists]>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>I received the draft of GRN and I found =
difference at 11 items, as I shared the list with supplier he send his =
representative to PO to solve the supply issue immediately, again I will =
follow this issue with supplier and will communicate you via =
phone.<o:p></o:p><![if =
!supportLists]>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>As we have agreed with supplier to exchange the =
two items which are quarantine right now at P-Stock and you received the =
replacement, please make them ready and pack in exact Qty and good =
package, please do the exchange process in presence of pharmacy =
committee.<o:p></o:p><![if =
!supportLists]>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>As I already talked with pharmacy team, so =
please inform them to prepare the GRN with all required info such as =
(expiry date, batch number, company &amp; country, Qty, =
etc..).<o:p></o:p><![if =
!supportLists]>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>As you all aware that AHF-Projects will be audit =
by 3rd party team, so please inform the AHF pharmacy in =
charge to fully get ready for assessment.<o:p></o:p><o:p>&nbsp;</o:p>Regards<o:p></o:p>Jamal<o:p></o:p><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a> [<a =
href=3D"mailto:dr.safar@jack.ngo">mailto:dr.safar@jack.ngo</a>] =
 Sent: Monday, March 15, 2021 6:50 PM To: <a =
href=3D"mailto:logitic.manager@jack.ngo">logitic.manager@jack.ngo</a> =
Cc: <a href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>; <a =
href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>; <a =
href=3D"mailto:ghani@jack.ngo">ghani@jack.ngo</a>; <a =
href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>; <a =
href=3D"mailto:mirzaee@jack.ngo">mirzaee@jack.ngo</a>; <a =
href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>; <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a> Subject:</b=
> Rejected and not received medicine<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Dr =
Sahib Jamal<o:p></o:p>Greetings from Kunduz =
office<o:p></o:p><o:p>&nbsp;</o:p>First of all thank you very much for a very quick =
procurement of AHF trauma medicine, the quality and the quantitiy is =
good and appreciated.<o:p></o:p><o:p>&nbsp;</o:p>However, =
there are difference in 11 items, as we explained and the report was =
shared with the pharmacy/warehouse responsible. I hope it has reached to =
you and I would like to kindly request on the process speed up. =
<o:p></o:p><o:p>&nbsp;</o:p>I would be glad to hear from your dear dr =
Sahib.<o:p></o:p><o:p>&nbsp;</o:p>Thank you &amp; Best =
Regards<o:p></o:p><img border=3D0 width=3D49 =
height=3D38 id=3D"_x0000_i1027" =
src=3D"cid:image009.jpg@01D7891A.FD9F0090"><=
o:p></o:p>&n=
bsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<o:p></o:p>Dr-Mohammad Hashim =E2=80=9CSafar=E2=80=9D =
MD/GP/Social Service =
Provider<o:p></o:p>Project Manager-AHF Project / NER PSEA =
Focal Point / Mental Health Focal Point<o:p></o:p>Just for Afghan Capacity and =
Knowledge&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
&nbsp;=D8=A8=D9=84=D9=86=D8=AF =D8=A8=D8=B1=D8=AF=D9=86 =
=D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =D9=88 =
=D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =
=D8=A7=D9=81=D8=BA=D8=A7=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9)&nbsp; =
<o:p></o:p>Address: Kunduz,Kocha Sinama,First =
Region<o:p></o:p>Beside Da Afghanistan Bank, House # =
08<o:p></o:p>Ph: +93 787 047 554 - +93 744 990 143 - =
+93792 716 026 =E2=80=93 +93777 469 663 =E2=80=93 +93706 179 =
758<o:p></o:p>Official Email: <a =
href=3D"mailto:Dr.Safar@jack.ngo">Dr.Safar@jack.ngo</a><o:p></o:p>Personal Email: <a =
href=3D"mailto:Dr.Safar001@outlook.com">Dr.Safar001@outlook.com</a> =
=E2=80=93 <a href=3D"mailto:Dr.Safar@yahoo.com">Dr.Safar@yahoo.com</a><o:p></o:p>Website:www.jack.ngo<o:p></o:p><=
p class=3DMsoNormal><o:p>&nbsp;</o:p></div></body></html>
------=_NextPart_001_001E_01D7B2CC.1AD94C80--

------=_NextPart_000_001D_01D7B2CC.1AD92570
Content-Type: image/jpeg;
	name="image003.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image003.jpg@01D7891A.FD9F0090>

------=_NextPart_000_001D_01D7B2CC.1AD92570
Content-Type: image/jpeg;
	name="image006.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image006.jpg@01D7891A.FD9F0090>
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------=_NextPart_000_001D_01D7B2CC.1AD92570
Content-Type: image/png;
	name="image007.png"
Content-Transfer-Encoding: base64
Content-ID: <image007.png@01D7891A.FD9F0090>

iVBORw0KGgoAAAANSUhEUgAAASIAAAEiAQAAAAB1xeIbAAAABGdBTUEAALGOfPtRkwAAAAlwSFlz
AAAOxAAADsQBlSsOGwAAABl0RVh0U29mdHdhcmUATWljcm9zb2Z0IE9mZmljZX/tNXEAAAEMSURB
VGje7dnBDYMwDIVhSwzASKzOSAxQySWOE1pooIcYqdWfA1LCd3uynVLRL9YsKBQKhfoLJb4GlWkZ
1oOlnEyoaGUbXVw5rS9QoSpFYu/mEpMHhrpNvWSFulvlfoS6UZVc8kC46l+ojup9IufAruY2qova
LQ/s4r6K6qNsDkt52Fbn8bFLCBWgRNJJBqOdPOSYECpEpVaUwZZVHQ2oSOWVYMNYS02oHmoIFaB8
LJemlO9FtURQgcpyWTciZxMZFaGsKW0TuXUTRYUqr4mPv8BQkcqnQuOrDypClcKonQl1n7I7kKl0
L2p+7UT1V7kf5RIZtfUPCypEWS5bOM2JjOqvzhcKhUKhfl49AcZAJK+rvDc4AAAAAElFTkSuQmCC

------=_NextPart_000_001D_01D7B2CC.1AD92570
Content-Type: image/jpeg;
	name="image009.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image009.jpg@01D7891A.FD9F0090>
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------=_NextPart_000_001D_01D7B2CC.1AD92570
Content-Type: image/jpeg;
	name="image001.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image001.jpg@01D7B2CC.17090AA0>

/9j/4AAQSkZJRgABAQEAeAB4AAD/2wBDAAoHBwkHBgoJCAkLCwoMDxkQDw4ODx4WFxIZJCAmJSMg
IyIoLTkwKCo2KyIjMkQyNjs9QEBAJjBGS0U+Sjk/QD3/2wBDAQsLCw8NDx0QEB09KSMpPT09PT09
PT09PT09PT09PT09PT09PT09PT09PT09PT09PT09PT09PT09PT09PT09PT3/wAARCABVAO8DASIA
AhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQA
AAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3
ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWm
p6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEA
AwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSEx
BhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElK
U1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3
uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD1+iii
gAooooAKK5Pxd46Xw1eR2cNn9onZBIxZ9qqCePfPFcSnxH1uLUp7lHQxSnItpBuRPoeDXo0MrxFe
HPFWXS/UhzSPYqK8usfitfJLIdQs4ZYyvyCHKEN2znPFdEPiVpA0RL1932pvlNmpy4P19PepqZZi
qbScb37DU4s6+uP+IniObR9PjsrTfHcXYP74cbFHXB9a5jWPiRNq2jXFrHBJZzvIvlvDJ/B3BPXP
0rjprue5CCeeWUIMLvcttHtmvSwOUTU1UrdHsRKotkd78N/EciXjaXdzzzee2YFI3BTgliWPIHHS
vS68e+GrRDxjF5pwxhkEee7Y/wAM13mveM7bTpJbHTle91UD5IYkLhT/ALRHp6Vz5nhXLF8tKO6T
f+Y4S93U6bFGDjOK8nA8eXeoJqHkXgkQ5VGwqfTZnBFdH4U0PWZryTVPENxdJOzAxRrcFQMdQyDj
B9K5q2AjShzSqRfktXcalfodpRRRXnlhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUVl+JtU
bRvDl9fIMyRR/IP9o8D9TXnmj/Fa9to7eDU7VLlE+WSdWxIR646E/wA67cPl9fE03UpK9tCXJJ2Z
6uSB1IH1rG1jxdo+iI32q8R5AceTCQ7/AJVxHi/4jWWraNNp+mQz/vwN0sgC7QDnAHXPHWvO8ivS
wWSSqLmr3j5ESqW2NTXdWbWtbur9gVEz5VSc7V6AflWfuqPNaVjYWYSO51i6ktraTmNIY98so6Eg
dAvufwzX0lo0YJW0WiMdyjvx3rUPh/UY9Gk1WeHyLRNoDScM5PTC9fxOBW1Y6Bpk/im2h0a5NzFN
YPc232jHMwyArD2Izg+lO8Io+pweItG1eaSN5olmmeXLOrRt8x+uK46uMtHmhsrN3Wtm7bFKJl20
1jo+jlrqzS7v7+JvKEh+W2jOQH/3ickewHrWHu962fFulXWm6u0022S1ufntZ4v9W8ePlA+gwMVh
ZrpwyUoe0Tvza/8AA+Wwn2Ol8GeHm8R6u0QujbRwLvd0bEnoNv8AjXsOlaNY6LbLDY26R/3nxlnP
ck9TXhvhm8nsfEunzWv+t89VAOcEMcEHHsa+gTwTXz2eupGqk37rWxrStYSisjxXd3en+HLu7srq
K1kgXzDLKm8BR2A7k8AfWuYsb7xElxolld6mZLzVSLmVfKVfs0CjLKPdsgZ9q8qlhHVp86kl9/RX
fTsaXO+orlZ9cvpPFGsix3S2mk2PMCjiW4OWA9eAMVHoV3r2q+EH1J9XsUnuQJYpBBlLZB95SO54
/Cm8HJR5pNLb8dV07ahc66iuN8Et4h1aC31jVNX32km/ZaiBV3jorEj6ZxVr4g6xeaLoEU+n3kVp
O9wke6RQcg9evTHUn0FDwkvbrDqSb262v9wX0udRRXCwanf6Jos2sS+IBr8cuLe0hSIIjTFsDkda
razd+MfDMVtqt7qlrcxyzJFNaLDhI93oevtmtI4CUpcqmuy3V322/OwuY9Dorzvxhr19b+MRp9v4
ki0q1W1Erl4wQjenTJJ610vgnU9Q1fwxBd6oAZnZgrhNvmIDhWx2zUVcFOnRjWbVnbv1+VunQaet
jform/GXiC40qz+yaXg6nPE8ikjIhjQZaQ/yHvXO614k1OOz8MxprkOnG/tRJczSoCR8oO859egH
rToYCpWUWmle/for30T7A2ejUVxL6hrOk2tnYW2qJrGqas+62nkjCRwxBQS+B1Her+kad4usdYT7
fqtpqGnOCZS0Wx1PooH9aUsJyxcnNeW+tu2n52C509Fcg3jO2TXdXluNQhi0/TIzEkG9Q9xKBliB
1OPujHfNWYdbvNJ8IRajq26fULxgYbZQB87/AOriX6DGT9amWDqxtdb2t89fw69gudNRXm03jHVd
O8A3t3d3aHV/7QktomCAqMEZAHoBmtzSfEFx4k1SwgsbjZaw2S3F9JHjLSOMLH7Y5J/CtJ5fVhFz
drJtX9P89l5hzI5P4leLjfXTaPYzo9pGR55VSCZAT8ue4Ht3rgN1bHjSyTT/ABTexpexXTPI0jmM
Y8skk7D7j2pmg6RbX1zaPqlxJb2dxcC3jMa5eVuM4zwAMjJ9+K+wwsaOGwsXHa1/NnPK7kZW7AzX
V6P4Eurye0/tS7tdPjuCCsUr/v3Xrwnbj1qhFptvYfENNNuiEtor8R5Y5AXd8uc/hRJbXmnav4ge
+lMt9bRPEZQ24tJIwUEH6E8dqK9WU0o0pWur7d9F/wAEEu5WvdHa18UyaOxIIuxACeu0sAD+RFTe
LiE8WajCo2xwS+TGo6KigBQPwFa/jqO4hvNE8QtBJDNdQRvKjrtImjxkEdsjH5Vc8Y+GbnxDcxeI
vDsDXlrfxq0iREFo3xg5H4c+hBrGlilzUqlR2TTV+nMmr/fYbW9jh7e5ltLhJ7aV4pozuR0OCp9q
3PB090us3ctvFLcS/YpwVQFmYsMD82IrPu7KPRoZILzy5dSkG3ylYMtsO5Yjguew7d+aYmv30Olj
T7WQW1uR+88gbXm/326n6dK66sfb02qa30u+36+RK0eptaB4jgsbOXQPEUJutJY4+U5e2cfxIR2z
6fh6VBdaBp9texyRa7YXGls4JkEmJgmeQY8Z3Y9P0rms123gLSfD3iNn07UreZL9QZElScqJV9Me
orHE01hVKvFtJ7pW++z2/q41robXww0fSbu7v9QXM0ttNttkl+9Gh6MR03H+lelTyGKCSRY2kZFL
BF6sQOg9zWfonhzTfDsMkemW/lCUgyMWLFsdMk1p18djsSsRXdRNtdLm8VZWOAuNZm8frY6Va6fd
2sHnLLqLTIQqKpz5YPck1p69pmt23iu31zQra3vCLU2rwTSbNnOQwPpXWO4VSzsFUdSxwKOoBHIP
Q0/rnK17OCUddHrvvrp5fcOxydlout6D4Zn/ALOa2utdu7jz7iSXhNzdceyjpUP/AAiup6f8PZ9F
spo5r+7ZjLIW2Iu85fHtjiux3LkjcMr1GelIssbsVSRGYdQrAml9cq3vZb327bfJdEFkRWFomn6d
bWkQASCJYxgegxWFrOg3Gt+LdMkuoIpNHsondlcgiSVuANvcAYroywXG4gZOBk9TQzqmN7KuTgbj
jNY0604Tc47u/wCIWMDxL4bOo+H0s9JWC1ntZluLZQu2MOpzggevNZg0rxF4mv7I+I7e1sdPs5RO
YIZN7XEg6Z9FrtMU1XVyQjKxXrg5xWtPF1IQ5Uk97Pqr72/r0Cxws3gObVrHWrjUhEmq3d0Z7WRT
uMQUfIpPp2IrsNK+2/2XbDVEiW8EYEwhOVyPSrQdC20Opb0BGaWprYqpVjyz2W3lpay8tASscBrP
gi+1yPVtQvEU6rcuIrNFuCqQQjAG7HXjJI55rR07wkZfEd3d6xZ281nDbRWllHJhxtUfM2O2T/Ou
uoBBYqCCw6jPIrR4+s4cl9NvRabfd+fcOVHN+JdH1Br3TNW0FIHvNO3ILeQ7VkjYYKg9iKzLbw7r
93eX2tXtzLZXkiA29ja3RMe8DjeTxjpwK7YsoUsWAUdSTxQGUvsDLuxnbnn8qmGMqQhypLte2tr3
t9/z8wsefP8ADt20DS7I21o16bkTahdnG4rkkhTjJznH4Vs654Zl8Q68JNQQnS7KA/ZYYpijSTHq
xI6ADgc11NFU8wruXM3rr+O9vy9A5UefaD4H1O2ltU1RLZrazt5zGqSbszyk5Jz1wMDNa/w98LXH
hbQ5Yb4R/a55d7+W24AAYAz+f511VFFbMK1aMoS2dvwu/wA2CikfPXjWz/s7xlqkGMKZzIv0b5v6
059asZPBtjYusialY3jSRSKPl8tuST75A49qk+JEjnx9qYkPIZAv02DFczur7rD0lXw1KU90k/w/
4Jyt2bOx+JSRnxPHqEBzDqNrFco2MZ4wT+gqja6le6F4f8+3meG61ObcJcfP5SDG4E8jLMeevymp
Nc1ZVtfCqyQpLNY2avLHIOGBbKq3sVAP0NY+s61da7qT3t6V3sAqoi4SNR0VR2ArHDUJTo06c1eK
387Oy0+5jk9WzfsfE2nSeDrnS9dhubydLn7Ra7ZMEkjnc5zgZznuc1gDVbuLzltZ5bWGU5aGCRkT
6YzVDdRursp4SnByaW7v5fJEuTJMgUbqj3Vc0/StQ1Z2XTrK4uipAbykLbc9MntW0uWCvJ2QtR+k
2Tapq9pYoSDcSrHkDOATyfyr3rQvBmi+HJmmsLY+ecjzpW3sB6A9q8r+GunX8XxAiDWsitaBxchx
jygVI598npXuFfI8QYqftVShL3ba2e9+5vSWl2FFFFfNGxw8elR+Otc1Z9WmnOn2Fx9kgtI3KDIA
LO2OpOaszra/DTwrdyx3VzdbnxbxXMmQHP3VHoB1P0qe/wDBcsurXN7pWtXmmC8IN1FCoIc9MjPQ
1oSeG4rjUNNubq5muE06MrFFLhg7kY8xj3avUliKb5Yud4ae76Lb5vr8ybHEeHL6C00Xxff3V4b+
B0jEk6sR5sjIdwX0G5sCm+HPCkzxaLNZ6Xd6bdwOk13fzS7RInJZVXJJzx2FdVN4GtrjT57OW8mM
dzffbbghFG89k9l4H5Vu6nZNqOmXFmk723nIYzJGMsoPXHvjitamYRTfsn8T130SSW2l+vTtoKx5
7qOv2viHX7G8hvPMNpqSR2llG+CyLkySsPfGB6D61c0jwvB440n+29duLmS4vCzQLHKVW2UEhQo6
ZGK6SLwnZwXekywsUi0uNkiiVBhyV2lmPUnH86zrfwLLY3Oyw8Qaha6Z5vmizjx8pznAbrin9bo8
nLRlyNbPyu9NF10f33YWfUreLdLg0n4frp73V7cyq6xWzPMQ8krHCgkdVGSce1Gr+GtI8OeAbmOY
TYiUTSNHMytNPt2jJznBJ6dK0fEXhCbxFfxTy6zdW0EDB4YYUX5HH8WT3/lV3W/DseuafaWM9zKt
vBKkjgAEzbegYn8zWMMVGMaadR780rX/AK/4LHYxvDvgq00zw0zyK41K6sWjuJmkbjcM4AJ4xx+V
ReAUvdasbLWNUY7LaH7NZxhjhscPK3qxxgemPeut1K0Ooabc2izNAZ42j8xRkoCMZFN0nTYdH0m1
0+3JMVtGI1LdTjufc1lPGSnTm5O8pP7lre35eg7FbxJrsPhzQ7jUJsMUG2NCcb3P3R/ntXn1jqy2
Ft4kvobz+0ri8ht4BIhyJLmQMCqegXPA9BXoOpaFFquqWF1dSs0VixkS32jY7kYDN9O1ZcfgW2XW
l1GS9ndhdm8MO1QhfGFGPRR0rXCVsPSpuM93v8mml+G/n5CaZyXhG4udZXTfC10soXTZ5J78MfvB
G+RCe/zHn6VZ1DR9L1fXPEmuX1zPZ2dmwgSaKYrvlVfmx687Rgd67DRvC1voup6pqEEzvc6i5cll
GI+SQB+J/Ss3Rvhzp2nTLNfXNxqUiSGVUnOIlcnJYIOM/WumWOo+0nUhJx0Wy3bd5fjpr0FZmr4P
F9/wiWnHVHd7togzmT72DyM++MVs0UV4tSfPNzta7uWFFFFQBWvNPsb2Mi+tbeZMcmWNWwPqa8CO
paLo/ibVZrfTotRthIwsUlP7tDu4Yj+IegrrPip40uxcSaDZpNbwDieVlKmb/ZX/AGffv9Ovlu6v
tMjy6caLnVbtLZX6f1+Bz1J66Fq8vJr+8murpy80zFnb1P8AQe1Q5pm6jdX0qioqyMR+altbae9u
o7a1iaWeVtqRqMlj6VX3V1Hw1DP4+0za0Y2sxO/uNpzj3rLE1PY0Z1F0Tf3DSu7HV2/wXklsbV5t
V8m5Zd08flbgmew56ivRvDuhw+HNFg063fzFiBzJsClyT1OK0qK/OcVmOJxUeWrK63OuMFHYasaI
zsqKrOcsQMFj7+tOoorhKCiijrQBWuNRtrW8tbSWTFxdkiGMAktgZJ9gPWoG1/Tkjv5GuQItPO25
k2nah9M9yOM46V53qGsXt74wuNRFwbLSWm/slb9UDNFjk7c9Nx/iwcVu+KtOSHTNN8H6IFgOoOxk
Y/MRGvzOzHqSTjnvXqfUIxcIzer1fl1f3Lp/wCeY6ltbsFhsZPP3LqDBbYKpJkyM8D0xyfSs288e
eHLHUPsVxqcQmB2sVBZUPoWHArz/AMN3Go3vh3U9QAJfRNPezs9uchmyWf6hcCtvUpPD1p8LFgtf
s0stzbqsSphpZJmxz653ZrZ5dSp1OSV3rbTz1vt2t+PYXMdxJrNhFd2ds11GZr0E26rz5gAySCOM
YpsWuadP9u8u6QjTzi6Y8CI4JOT+BrzvxNNdeGr7wgIoBNfW1m0UceODIwCjp6E1meFLS/1bULvw
3cBtjXhudUn3Z3qnGz8WojlcHR9tzaWv/wCTNN/clbzYc2tj1d9csI9Nt7+SYpb3LKsJZCC5b7oA
681V1vxbo/h6ZYdTu/Kmdd6xqhYkZxnisbVb+1uviDYWNxPBBZ6RAbt/McKplI2oOfQHNZmtXc2r
ePZJNOvdMtjpEARZLwZWR5OuPUgfl+NY0cFCUlz3tZyf6K9n5dOo2zqYvGWjS6HJrAuXFjHJ5TSN
Ew+bjgDGT1qfSfFGj65n+ztQhmZV3smdrKPcGsTx/dxQ6JY6VcTwwDUbhIppThVWMfNI3t/9euR8
Vxw6usus+H7c2ek2EYtpLmKPy/tIdgG2+qgd/eroYGlXinrHmbs912V9Fdt3WgN2O8/4T/w1/aH2
P+1YfMzjdg+Xn03dKua14p0jw8Yhqd2ImlUsihSxYDvxWDq+o+GtKh0nTo9Hj1OCbmBLZEkYFQCD
t6kms3xBfvrPjG0jsZ7GxOk2v2gnUFwBI4GEI9QCOO1Kng6U5RfLJRs27tdNF00102C7O00PxDp/
iK3ln0yR5Ion2MzRlecZ71pVDZq62cIlMbS7FLtGuFZsckD0qavMqcvM+RWX3/5FBRRRUAFFFFAF
e9sLTUrcwX1tDcxH+GVAwrh9a+D2jXhM2nTzWBzyg/eJ+AJyPzoorqw2Mr4d3pTa/rtsS4p7lKP4
H2hXLazOT7QAf1qpp/wdtJdXura51WdooFUjy4grHOe5J9PSiiu6Oc45xlep07Lv6EunHsa8HwV0
WGffPe3s0Y/5Z5VfzIFdVo/hPRNBYPpunQxSgY80jc//AH0eaKK4q2PxNdWqVG0UopbI16KKK5Cg
ooooAKCMgj1oooAzT4d0ltPSwOnwG0STzRCV+Xf/AHj6mrR0+0OoJfGBDdJH5SSkfMq+g9BRRVup
N7t/8PuIZYaVY6XbNb2NrFBE7FmVRwxPUn1qjZeD9A07UPttppVvFc5yHAJ2n1UHgfhRRTVaor2k
9d9d/Udi/NpllcX8N9NbRyXUAIilYZKfT0ostLstOadrK1ihad98rIOXb1J79TRRSc5W5b6AUrjw
loV5ey3l1pdtPcSkM8kq7iT+P0pF8IaCLtro6VatcNJ5pkddx3ZznnpRRVfWKyVud/ewsixqOgaZ
q9zDcajZRXUkIIj83JC5OTx0q49vDJbNbvDG0DLsMRUbSvpj0ooqHUm0k3otvIDN0rwtouh3Dz6b
p0MEz9ZBksB6AnoPpSTeEtCub2W8uNLtprmVt7ySruJP49KKKv6xVvzczu+t2Fka9FFFZAFFFFAB
RRRQB//Z

------=_NextPart_000_001D_01D7B2CC.1AD92570
Content-Type: image/jpeg;
	name="image002.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image002.jpg@01D7B2CC.17090AA0>
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------=_NextPart_000_001D_01D7B2CC.1AD92570
Content-Type: image/jpeg;
	name="image005.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image005.jpg@01D7B2CC.17090AA0>
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------=_NextPart_000_001D_01D7B2CC.1AD92570--